Literature DB >> 28551724

The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: a cross-sectional study.

Rulan Yin1,2, Haixia Cao2, Ting Fu1,2, Qiuxiang Zhang1,2, Lijuan Zhang1,2, Liren Li3, Zhifeng Gu4.   

Abstract

The aim of this study was to assess adherence rate and predictors of non-adherence with urate-lowering therapy (ULT) in Chinese gout patients. A cross-sectional study was administered to 125 gout patients using the Compliance Questionnaire on Rheumatology (CQR) for adherence to ULT. Patients were asked to complete the Treatment Satisfaction Questionnaire for Medication version II, Health Assessment Questionnaire, Confidence in Gout Treatment Questionnaire, Gout Knowledge Questionnaire, Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, and 36-Item Short Form Health Survey. Data were analyzed by independent sample t test, rank sum test, Chi-square analysis as well as binary stepwise logistic regression modeling. The data showed that the rate of adherence (CQR ≥80%) to ULT was 9.6% in our investigated gout patients. Adherence was associated with functional capacity, gout-related knowledge, satisfaction with medication, confidence in gout treatment and mental components summary. Multivariable analysis of binary stepwise logistic regression identified gout-related knowledge and satisfaction of effectiveness with medication was the independent risk factors of medication non-adherence. Patients unaware of gout-related knowledge, or with low satisfaction of effectiveness with medication, were more likely not to adhere to ULT. Non-adherence to ULT among gout patients is exceedingly common, particularly in patients unaware of gout-related knowledge, or with low satisfaction of effectiveness with medication. These findings could help medical personnel develop useful interventions to improve gout patients' medication adherence.

Entities:  

Keywords:  Adherence; China; Gout; Urate-lowering therapy

Mesh:

Substances:

Year:  2017        PMID: 28551724     DOI: 10.1007/s00296-017-3746-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  35 in total

1.  British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.

Authors:  Kelsey M Jordan; J Stewart Cameron; Michael Snaith; Weiya Zhang; Michael Doherty; Jonathan Seckl; Aroon Hingorani; Richard Jaques; George Nuki
Journal:  Rheumatology (Oxford)       Date:  2007-05-23       Impact factor: 7.580

Review 2.  Medication adherence in gout: a systematic review.

Authors:  Mary A De Vera; Greg Marcotte; Sharan Rai; Jessica S Galo; Vidula Bhole
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-10       Impact factor: 4.794

3.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

4.  Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate.

Authors:  Amal B Abdul-Sattar; Sahar A Abou El Magd
Journal:  Rheumatol Int       Date:  2014-11-26       Impact factor: 2.631

5.  Comparison of drug adherence rates among patients with seven different medical conditions.

Authors:  Becky A Briesacher; Susan E Andrade; Hassan Fouayzi; K Arnold Chan
Journal:  Pharmacotherapy       Date:  2008-04       Impact factor: 4.705

6.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Tuhina Neogi; Tim L Th A Jansen; Nicola Dalbeth; Jaap Fransen; H Ralph Schumacher; Dianne Berendsen; Melanie Brown; Hyon Choi; N Lawrence Edwards; Hein J E M Janssens; Frédéric Lioté; Raymond P Naden; George Nuki; Alexis Ogdie; Fernando Perez-Ruiz; Kenneth Saag; Jasvinder A Singh; John S Sundy; Anne-Kathrin Tausche; Janitzia Vaquez-Mellado; Steven A Yarows; William J Taylor
Journal:  Ann Rheum Dis       Date:  2015-10       Impact factor: 19.103

7.  Knowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practice.

Authors:  Bart Spaetgens; Tobias Pustjens; Lieke E J M Scheepers; Hein J E M Janssens; Sjef van der Linden; Annelies Boonen
Journal:  Clin Rheumatol       Date:  2016-02-22       Impact factor: 2.980

8.  Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis.

Authors:  Yunfei Xia; Rulan Yin; Ting Fu; Lijuan Zhang; Qiuxiang Zhang; Genkai Guo; Liren Li; Zhifeng Gu
Journal:  Patient Prefer Adherence       Date:  2016-05-04       Impact factor: 2.711

Review 9.  Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis.

Authors:  Rui Liu; Cheng Han; Di Wu; Xinghai Xia; Jianqiu Gu; Haixia Guan; Zhongyan Shan; Weiping Teng
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

10.  Stability and Repeatability of the Distress Thermometer (DT) and the Edmonton Symptom Assessment System-Revised (ESAS-r) with Parents of Childhood Cancer Survivors.

Authors:  Tatsiana Leclair; Anne-Sophie Carret; Yvan Samson; Serge Sultan
Journal:  PLoS One       Date:  2016-07-25       Impact factor: 3.240

View more
  3 in total

1.  Visceral adipose accumulation increased the risk of hyperuricemia among middle-aged and elderly adults: a population-based study.

Authors:  Xiaolin Huang; Xiaohong Jiang; Long Wang; Lu Chen; Yang Wu; Pei Gao; Fei Hua
Journal:  J Transl Med       Date:  2019-10-10       Impact factor: 5.531

2.  Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China.

Authors:  Nan Jiang; Pingting Yang; Shengyun Liu; Hongbin Li; Lijun Wu; Xiaofei Shi; Yongfei Fang; Yi Zhao; Jian Xu; Zhenyu Jiang; Zhenbiao Wu; Xinwang Duan; Qian Wang; Xinping Tian; Mengtao Li; Xiaofeng Zeng
Journal:  Patient Prefer Adherence       Date:  2020-06-23       Impact factor: 2.711

3.  Depressive Symptoms and the Effectiveness of a Urate-Lowering Therapy in a Clinical Trial.

Authors:  Sylvie Mrug; Catheryn Orihuela; Elizabeth Rahn; Amy Mudano; Jeffrey Foster; Kenneth Saag; Angelo Gaffo
Journal:  ACR Open Rheumatol       Date:  2020-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.